A detailed history of Royal Bank Of Canada transactions in Novo Nordisk A S stock. As of the latest transaction made, Royal Bank Of Canada holds 6,004,120 shares of NVO stock, worth $632 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,004,120
Previous 5,901,988 1.73%
Holding current value
$632 Million
Previous $842 Million 15.14%
% of portfolio
0.15%
Previous 0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $12.2 Million - $14.9 Million
102,132 Added 1.73%
6,004,120 $715 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $49.7 Million - $59.5 Million
405,231 Added 7.37%
5,901,988 $842 Million
Q1 2024

Nov 05, 2024

SELL
$102.11 - $135.92 $41.4 Million - $55.1 Million
-405,231 Reduced 6.87%
5,496,757 $706 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $176 Million - $234 Million
1,722,038 Added 45.62%
5,496,757 $706 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $11.6 Million - $13.9 Million
131,658 Added 3.61%
3,774,719 $390 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $183 Million - $402 Million
2,015,829 Added 123.88%
3,643,061 $331 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $7.18 Million - $7.95 Million
46,060 Added 2.91%
1,627,232 $263 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $20.2 Million - $24.3 Million
-152,741 Reduced 8.81%
1,581,172 $252 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $320,981 - $423,582
3,130 Added 0.18%
1,733,913 $235 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $9.11 Million - $11.2 Million
-95,567 Reduced 5.23%
1,730,783 $172 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $1.22 Million - $1.43 Million
11,774 Added 0.65%
1,826,350 $204 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $1.99 Million - $2.4 Million
21,370 Added 1.19%
1,814,576 $202 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $9.53 Million - $11.6 Million
99,354 Added 5.87%
1,793,206 $201 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $5.3 Million - $6.7 Million
62,829 Added 3.85%
1,693,852 $163 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $110 Million - $138 Million
1,631,023 New
1,631,023 $137 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.